
Early integration of clinical, operational, and patient-level insights during trial development can help close the gap between evidence generation and commercial performance, improving alignment between product value and real-world adoption.
Giovanni Guzzo, PhD
Sr. Clinical Country & Site Lead
Associate Director, Global Clinical Operations
Biogen

Early integration of clinical, operational, and patient-level insights during trial development can help close the gap between evidence generation and commercial performance, improving alignment between product value and real-world adoption.